Searched for
GMP SURVEILLANCE
Zydus Biologics’ Ahmedabad injectable facility gets 7 observations in USFDA inspectionZydus Lifesciences has made headlines as its Zydus Biologics injectable plant in Ahmedabad underwent a USFDA inspection between April 27 an...- Drug regulator oversight sought for nutraceuticals; NGO flags quality, pricing concernsA Gujarat NGO is pushing the government to regulate nutraceuticals like medicines. They cite concerns about product quality and unregulated...
- Cough syrup deaths: Ensure drug manufacturers comply with Revised Schedule M norms, govt to statesThe Union health ministry addressed cough syrup quality. A meeting reviewed drug norm compliance. This followed child deaths linked to syru...
- Aditya Infotech IPO Opens: GMP at Rs 45 – Should you apply for the Rs 1,300 crore issue?Aditya Infotech's Rs 1,300 crore IPO opened on July 29, with a price band of ₹640–675 per share, aiming to raise funds for working capital....
- Aditya Infotech shares soar 51% on debut, biggest IPO listing gain of 2025Aditya Infotech shares: With this performance, Aditya Infotech has become the most successful IPO of 2025 in terms of listing gains. In com...
- Aditya Infotech IPO GMP hints at 44% listing premium ahead of debut tomorrowThe Aditya Infotech IPO, open from July 29 to 31, witnessed strong demand across all investor categories, getting subscribed 106.23 times i...
- Aditya Infotech IPO allotment today: Check status, GMP and other detailsAditya Infotech's IPO allotment status will be finalized today. The IPO witnessed huge investor demand. It was subscribed over 106 times. R...
- Aditya Infotech IPO subscribed over 100 times as on final day. Check GMP, review, and other detailsAditya Infotech, a leading distributor of electronic security equipment, saw 24% revenue CAGR and over 2x PAT growth between FY22–FY24. Wit...
- Aditya Infotech IPO subscribed 6.9x on Day 2; should you apply? Check GMP, review, and moreAditya Infotech’s Rs 1,300 crore IPO, a fresh issue of 1.93 crore shares, is open from July 29 to 31 with a price band of Rs 640–675 per sh...
- Takyon Networks IPO opens for subscription. Key details to know before subscribingTakyon Networks is set to launch its Initial Public Offering today. The IPO aims to raise Rs 20.48 crore. The offer will be available on th...
- Aditya Infotech IPO subscribed over 2 times on Day 1. Check GMP, review, and moreAditya Infotech's Rs 1,300 crore IPO opened on July 29. The IPO witnessed 150% subscription on day one. Retail investors showed robust inte...
- Aditya Infotech GMP robust at 30% ahead of IPO. Should you subscribe?Aditya Infotech, known for CP Plus, is launching its IPO. The IPO is gaining traction in the grey market. Shares are trading at a premium. ...
- ITI shares in focus after bagging Rs 95 crore order from Uttarakhand govShares of ITI will be in focus on Tuesday after the company announced it received a Rs 95 crore order for a Mining Digital Transformation &...
- All 4 IPOs launched today subscribed fully. Check GMP and other detailsAll four SME IPOs—Three M Paper Boards, Prizor Viztech, Sati Poly Plast, and Aelea Commodities—close on July 16. Sati Poly Plast's Rs 17.36...
- Prizor Viztech IPO opens today: Check issue size, price band, GMP and other detailsThe SME IPO of Prizor Viztech, which offers CCTV solutions across verticals, seeks to raise Rs 25 crore. Shares are priced at Rs 82-87, and...
- WHO Good Distribution Practices certification lifts Venus Remedies by 3%SGS awarded the WHO GDP certification to Venus Remedies following an elaborate audit. Internationally accepted pharmaceutical GDP regulatio...
- Decks cleared for import of Bharat Biotech's Covaxin, Russia's Sputnik V into BrazilNational Health Surveillance Agency of Brazil-Anvisa had earlier denied permission to import Covaxin after authorities found that the India...
- Bharat Biotech submits new request to Brazilian regulator on GMP issues for CovaxinAccording to the National Health Surveillance Agency of Brazil Anvisa, Bharat Biotech made the request on May 25 and a day before the Minis...
- USFDA inspection of Unichem Lab's Roha facility completed with no observationDrug firm Unichem Laboratories on Monday said the US health regulator has completed inspection of its Roha facility in Maharashtra without ...
- CDSCO plans surprise checks at drug manufacturing sitesThe move comes amid growing concern about the quality of medicines made in India and demands for a tighter inspection mechanism by regulato...
Load More
